S

Super Speciosa

Direct-to-consumer kratom with verified lab testing

Overview

Super Speciosa sells kratom botanical products directly to consumers via its website, offering powders, capsules, tablets, tea bags, gummies, and tinctures made from pure Mitragyna speciosa leaf with no fillers. The company controls the supply chain from ethically sourced leaves in Southeast Asia to in-house manufacturing and packaging, and it provides third-party lab test results for every batch that customers can access by scanning a QR code. They avoid artificially high 7-hydroxymitragynine levels and emphasize safety and transparency. Their products are GMP-qualified by the American Kratom Association and were chosen for an FDA kratom clinical trial due to their documented purity and manufacturing processes. The goal is to deliver safe, traceable kratom products with clear quality standards, building trust with customers and differentiating themselves through rigorous quality control and full product transparency.

Work here?Claim your company

About Super Speciosa

Simplify's Rating
Why Super Speciosa is rated
C
Rated B on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

HealthcareConsumer Goods

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2016

Get referred to Super Speciosa

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Pennsylvania's 2026 House Bill 2657 advanced 202-0, legitimizing adult kratom markets.
  • Ohio court relief on February 25, 2026 kept natural-leaf products legal there.
  • Super Speciosa launched Caramel Apple kratom gummies on October 7, 2026.

What critics are saying

  • DEA's July 1, 2026 7-OH scheduling targets the company's core product category.
  • Massachusetts' 2026 one-year kratom ban shows state shutdowns can erase revenue overnight.
  • FDA still treats kratom as unlawfully marketed, enabling seizure, injunctions, or wholesale platform bans.

What makes Super Speciosa unique

  • Fort Lauderdale FDA-registered manufacturing and batch QR lab reports differentiate Super Speciosa.
  • It supplied raw leaf for the 2026 published FDA-linked kratom study.
  • AKA GMP qualification since 2019 gives retail buyers a rare trust signal.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Paid Vacation
  • Remote Work Options
  • Mentorship Program
  • Training Programs
  • Flexible Work Hours

Recently Posted Jobs

Sign up to get curated job recommendations

Super Speciosa is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs